Literature DB >> 3055972

Activation of complement in IgA nephropathy.

R J Wyatt1, B A Julian.   

Abstract

Considerable evidence supports a role for the complement system in the pathogenesis of IgA nephropathy (IgAN). The alternative pathway components C3 and properdin (P) and the membrane attack complex (C5b-9) are generally found in the mesangial deposits in IgAN, while the classical pathway components C1q and C4 are usually absent. This pattern of immunofluorescence staining for complement components suggests activation of the alternative and terminal pathways in most patients. Despite normal serum concentrations of C3 and other complement proteins, fragments generated by activation of C3, including iC3b, C3d, and iC3b-C3d neoantigen, and sometimes C4, are often detected in plasma. We found that the severity of the histologic changes in the renal biopsy specimens correlated with plasma iC3b-C3d neoantigen concentrations as measured by an enzyme-linked immunosorbent assay. However, no other clinical feature correlated with the plasma concentrations of this neoantigen.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3055972     DOI: 10.1016/s0272-6386(88)80042-8

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  19 in total

1.  Can one predict the prognosis in patients with IgA nephropathy from the analysis of serum complement?

Authors:  R J Wyatt
Journal:  Pediatr Nephrol       Date:  1989-10       Impact factor: 3.714

Review 2.  Biomarkers in IgA nephropathy: relationship to pathogenetic hits.

Authors:  Margaret Colleen Hastings; Zina Moldoveanu; Hitoshi Suzuki; Francois Berthoux; Bruce A Julian; John T Sanders; Matthew B Renfrow; Jan Novak; Robert J Wyatt
Journal:  Expert Opin Med Diagn       Date:  2013-11

3.  The combined role of galactose-deficient IgA1 and streptococcal IgA-binding M Protein in inducing IL-6 and C3 secretion from human mesangial cells: implications for IgA nephropathy.

Authors:  Roland Schmitt; Anne-Lie Ståhl; Anders I Olin; Ann-Charlotte Kristoffersson; Johan Rebetz; Jan Novak; Gunnar Lindahl; Diana Karpman
Journal:  J Immunol       Date:  2014-05-21       Impact factor: 5.422

Review 4.  Immunoglobulin A nephropathy: a pathophysiology view.

Authors:  Rafaela Cabral Gonçalves Fabiano; Sérgio Veloso Brant Pinheiro; Ana Cristina Simões E Silva
Journal:  Inflamm Res       Date:  2016-06-28       Impact factor: 4.575

Review 5.  Pathogenesis of immunoglobulin A nephropathy: recent insight from genetic studies.

Authors:  Krzysztof Kiryluk; Jan Novak; Ali G Gharavi
Journal:  Annu Rev Med       Date:  2012-10-16       Impact factor: 13.739

Review 6.  Current Understanding of the Role of Complement in IgA Nephropathy.

Authors:  Nicolas Maillard; Robert J Wyatt; Bruce A Julian; Krzysztof Kiryluk; Ali Gharavi; Veronique Fremeaux-Bacchi; Jan Novak
Journal:  J Am Soc Nephrol       Date:  2015-02-18       Impact factor: 10.121

7.  Mesangial C4d deposition may predict progression of kidney disease in pediatric patients with IgA nephropathy.

Authors:  Rafaela Cabral Gonçalves Fabiano; Stanley de Almeida Araújo; Eduardo Alves Bambirra; Eduardo Araújo Oliveira; Ana Cristina Simões E Silva; Sérgio Veloso Brant Pinheiro
Journal:  Pediatr Nephrol       Date:  2017-02-23       Impact factor: 3.714

8.  Extensive complement activation in hereditary porcine membranoproliferative glomerulonephritis type II (porcine dense deposit disease).

Authors:  J H Jansen; K Høgåsen; T E Mollnes
Journal:  Am J Pathol       Date:  1993-11       Impact factor: 4.307

9.  Glomerular mannose-binding lectin deposition is a useful prognostic predictor in immunoglobulin A nephropathy.

Authors:  L-L Liu; N Liu; Y Chen; L-N Wang; Y Jiang; J Wang; X-L Li; L Yao; Q-L Fan
Journal:  Clin Exp Immunol       Date:  2013-10       Impact factor: 4.330

10.  IgA nephropathy in hereditary angioedema.

Authors:  J Srinivasan; P Beck
Journal:  Postgrad Med J       Date:  1993-02       Impact factor: 2.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.